Standardized Locomotor and Sensory behavior changes in a graded contusive spinal cord injury model
Johana Bastidas1, Megan R. Detloff2, Linda Jones3, Marco Baptista3,Karim Fouad4, Taleen Hanania1. 1 Psychogenics, Paramus, New Jersey, US 2Department of...
Preclinical Alzheimer’s Disease Studies
At PsychoGenics, our experienced scientists provide expert preclinical Alzheimer’s disease (AD) studies to develop your therapy. Our research focuses on...
Preclinical Amyotrophic Lateral Sclerosis (ALS) Studies
PsychoGenics leverages transgenic models to advance preclinical studies of amyotrophic lateral sclerosis (ALS), a progressive paralytic disorder characterized by motor...
Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer
Irshad S, Bansal M, Guarnieri P, Davis H, Zen A.L, Baran B, Pinna C.M, Rahman H, Biswas S, Bardella C,...
Use of Phenotypic Screening in Mice in the Development of a Novel Non-D2-Receptor-Targeting Drug for the Treatment of Schizophrenia
E. Leahy, M. Varney and D. Brunner SEP-363856, a novel, first-in-class drug treatment being developed by Sunovion Pharmaceuticals, showed robust...
Preclinical Depression Studies
PsychoGenics leverages rigorous, well-validated testing methods to conduct the highest-quality preclinical depression studies for your innovative treatment. Rooted in a...
Preclinical Postoperative Pain Studies
Preclinical Postoperative Pain With rodent postoperative pain models that accurately predict clinical treatment effects, and expertly conducted assessments, we provide...
Preclinical Seizure Studies
Our synchronized Video-EEG system allows us to capture both spontaneous and chemical-induced seizure data, providing valuable insights into the impact of...
Characterization of The APP/PS1 Mouse Model of Alzheimer’s Disease
The APP/PS1 mouse model expresses mutated forms of the human amyloid precursor protein (APPsw) and presenilin 1 (m146L), facilitating the...